Data

The Pistoia Alliance has announced four new strategic priorities that will enable the not-for-profit group to accelerate key areas within R&D.  The Pistoia Alliance has appointed steering committees to lead collaboration in the areas of sustainability, adoption of AI, the use of real-world data and data-driven value. The priorities were selected in response to the […]

In this listicle, Thermo Fisher Scientific outlines three problems solved by the Thermo Fisher Connect Platform Team Edition and below, they expand to five reasons why companies should consider this platform.  How do you secure your data? How do you share instruments? The Thermo Fisher Connect Platform Team Edition is a cloud platform where teams […]

In this listicle, Thermo Fisher Scientific outlines three problems solved by the Thermo Fisher Connect Platform Team Edition and below, they expand to five reasons why companies should consider this platform.  How do you secure your data? How do you share instruments? The Thermo Fisher Connect Platform Team Edition is a cloud platform where teams […]

This is the latest episode of the free DDW narrated podcast, “What’s at the forefront of innovation?” It covers three articles written for the for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Can animal genomics help find therapies for human disease?”, “Understanding and innovating in immunology”, and “Cell and gene […]

Genomics is driving a revolution in drug development and, in the long run, the state of public healthcare. Advances in sequencing are leading to scientific breakthroughs in preventative care, faster diagnoses, and proactive medical interventions. Jack Dix, Head of Healthcare Strategy and Consulting at Kainos, expands.  Genetic insights are also guiding healthcare closer to precision […]

Shelley McLendon, SVP of Vaccine and Infectious Diseases Program Management at ICON, attended the World Vaccine Congress Europe from 16-19 October 2022 in Barcelona, Spain. There, McLendon spoke on the topic of fortifying vaccines against future pandemics, specifically discussing: The importance of disease surveillance and reporting with regard to emerging infectious diseases; promising developments in […]

Social media started gaining traction in the early 2000s and has been growing steadily but DDW’s Megan Thomas has observed that it seems to have recently expanded into the world of business and significantly, the wider scientific industries. Here, she unpacks some of the areas in which social media plays a role in the drug […]

A new study led by Medical Research Council-funded researchers from UCL has found that tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases.  Context   In 2018, the UK’s department of health announced an NHS Genomic Medicine Service, which allows patients with rare diseases to have their […]

Genomic healthcare data is critical to identify disease risk, ancestry, traits and response to medicines and aids in the development of new targeted therapies – precision medicines. DDW’s Megan Thomas observes developments of accessibility in this sector and the potential impact.  The origins  One might argue that this all started getting exciting with the launch […]

Throughout 2022, Exscientia has progressed AI-driven capabilities for virtual biologics design, such as human antibodies, and is now establishing an automated biologics laboratory in Oxford to internally generate and profile novel antibodies.   Context  Current approaches to optimise antibodies, even those that use machine learning, still depend on discovering antibodies by experimental screening methods. Combining generative […]

Collaborative Drug Discovery (CDD) is hosting a webinar in which CDD’s Eric Gifford speaks with two industry experts, Dr Josh Horan and Dr Michael Kappler about their experience working with data at biotech companies.   The live webinar will take place on December 1, 2022 at 8AM (PT), 11AM (ET) or 4PM (GMT).  Discussion topics will include:  […]

Barry Bunin, PhD, CEO of Collaborative Drug Discovery explores the rise of electronic lab notebooks and why researchers should be transitioning to digital methods of recording data.  The laboratory notebook has been around for centuries. Scientific breakthroughs from the 18th Century through to today have at one point been recorded by hand in such a […]

Sekkei Bio, an India-based company dedicated to building technologies for drug and vaccine design with global impact, has implemented CDD Vault as the main platform to house its research data.   Sekkei Bio has made progress toward finding therapies for diabetes and pain, and has a management team with a track record of successfully bringing drugs […]

AstraZeneca has identified an additional target for its idiopathic pulmonary fibrosis (IPF) pipeline using an AI system designed by drug discovery company BenevolentAI. It is now the third target from that collaboration that has been identified using BenevolentAI’s platform. AstraZeneca is using the company’s Benevolent Platform across two disease areas – IPF and chronic kidney […]

Listen to this article on the DDW Podcast: Lu Rahman spoke to Ashley Zehnder, CEO of Fauna Bio, a biotech harnessing the power of comparative and functional animal genomics to find better therapies for human disease, including neurologic, metabolic, fibrotic and cardiovascular disorders. “Comparative genomics is the process of using data from mammals and other species […]

Life sciences company PerkinElmer is exhibiting at the Bio-IT World Conference and Expo this week ( 3-5 May) in Boston US.   The company is exhibiting a range of solutions that can help researchers in labs make well-informed, data-driven decision on therapeutic candidates by using cloud-based informatics solutions and strategic IT services.  The company is showcasing […]